We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B Turnover 27.25%
1-Year Est. Return 31.07%
 

Two Sigma Advisers is the investment manager behind a small set of Two Sigma hedge funds, including Two Sigma Absolute Return Cayman Fund, Two Sigma Absolute Return Fund and Two Sigma Strategies Allocator Fund. Revocable trusts of David Siegel and John Overdeck, who founded the investment and trading firm Two Sigma Investments in 2001, are among its limited partners.

This Fund
S&P 500
This Quarter Est. Return
+4.17%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.06%
AUM
$51.4B
AUM Growth
+$1.46B
Cap. Flow
+$988M
Cap. Flow %
1.92%
Top 10 Hldgs %
18.85%
Holding
2,686
New
375
Increased
1,038
Reduced
898
Closed
357
Avg Time Held
2.6 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$512M
2
AMD icon
Advanced Micro Devices
AMD
+$401M
3
RBLX icon
Roblox
RBLX
+$384M
4
TSM icon
TSMC
TSM
+$371M
5
TJX icon
TJX Companies
TJX
+$271M

Sector Composition

Rank Sector Weight
1 Technology 27.47%
2 Consumer Discretionary 14.54%
3 Financials 14.39%
4 Healthcare 12.45%
5 Industrials 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DNA icon
2226
Ginkgo Bioworks
DNA
$534M
$98.5K ﹤0.01%
11,856
-19,252
-62% -$207K
2022 Q4
12 quarters
SMWB icon
2227
Similarweb
SMWB
$731M
$97.4K ﹤0.01%
13,000
-11,800
-48% -$95.1K
2024 Q1
7 quarters
TG icon
2228
Tredegar
TG
$193M
$96.9K ﹤0.01%
13,500
-12,700
-48% -$96.3K
2023 Q2
10 quarters
TH icon
2229
Target Hospitality
TH
$1.22B
$96.9K ﹤0.01%
+12,100
New +$91.8K
2025 Q4
0 quarters
CDXS icon
2230
Codexis
CDXS
$124M
$96.8K ﹤0.01%
59,400
+31,900
+116% +$65.1K
2020 Q3
21 quarters
SLN icon
2231
Silence Therapeutics
SLN
$1.23B
$96.7K ﹤0.01%
15,900
-26,700
-63% -$171K
2024 Q1
7 quarters
YARW icon
2232
Yarrow Bioscience
YARW
$128M
$94.6K ﹤0.01%
3,262
+2,130
+188% +$42.8K
2025 Q3
1 quarter
ADAM icon
2233
Adamas Trust
ADAM
$433M
$94.5K ﹤0.01%
12,951
-83,850
-87% -$595K
2024 Q4
4 quarters
XOS icon
2234
Xos
XOS
$27.1M
$92.5K ﹤0.01%
51,100
-5,500
-10% -$13.5K
2025 Q3
1 quarter
FBIO icon
2235
Fortress Biotech
FBIO
$63.3M
$92.4K ﹤0.01%
+25,250
New +$72K
2025 Q4
0 quarters
GSM icon
2236
Ferroglobe
GSM
$435M
$91.4K ﹤0.01%
19,700
+1,900
+11% +$8.77K
2018 Q4
28 quarters
VTGN icon
2237
VistaGen Therapeutics
VTGN
$8.96M
$91.2K ﹤0.01%
137,732
-19,300
-12% -$69.7K
2024 Q4
4 quarters
IRLA icon
2238
IRulya Therapeutics
IRLA
$451M
$90.8K ﹤0.01%
+136
New +$68.4K
2025 Q4
0 quarters
KRRO icon
2239
Korro Bio
KRRO
$181M
$90K ﹤0.01%
11,237
-172
-2% -$4.02K
2025 Q3
1 quarter
HIMX icon
2240
Himax Technologies
HIMX
$1.35B
$89.3K ﹤0.01%
10,900
-149,300
-93% -$1.26M
2023 Q3
9 quarters
SNDL icon
2241
Sundial Growers
SNDL
$329M
$88.6K ﹤0.01%
53,400
+700
+1% +$1.4K
2024 Q4
4 quarters
CRSR icon
2242
Corsair Gaming
CRSR
$1.25B
$88.5K ﹤0.01%
14,900
+3,200
+27% +$22.2K
2025 Q3
1 quarter
RPAY icon
2243
Repay Holdings
RPAY
$371M
$88K ﹤0.01%
24,100
-7,800
-24% -$31.3K
2023 Q4
8 quarters
MRCC icon
2244
DELISTED
Monroe Capital Corp
MRCC
$87.9K ﹤0.01%
13,800
-28,200
-67% -$187K
2016 Q2
38 quarters
NAGE icon
2245
Niagen Bioscience
NAGE
$162M
$87.8K ﹤0.01%
+13,800
New +$96K
2025 Q4
0 quarters
JELD icon
2246
JELD-WEN Holding
JELD
$63.9M
$85.9K ﹤0.01%
34,900
-102,700
-75% -$337K
2022 Q3
13 quarters
INAB icon
2247
IN8bio
INAB
$8.32M
$85.1K ﹤0.01%
36,351
-9,400
-21% -$17.9K
2025 Q3
1 quarter
RFIL icon
2248
RF Industries
RFIL
$75.9M
$82.7K ﹤0.01%
+14,300
New +$99K
2025 Q4
0 quarters
SFL icon
2249
SFL
SFL
$1.63B
$82K ﹤0.01%
+10,500
New +$80.6K
2025 Q4
0 quarters
ASM icon
2250
Avino Silver & Gold Mines
ASM
$658M
$82K ﹤0.01%
+13,200
New +$71K
2025 Q4
0 quarters

Similar funds

Two Sigma Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, Two Sigma Advisers held 2,686 positions worth $51.4B, up 2.9% from $50B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Two Sigma Advisers's Q4 2025 filing shows 375 new, 1,038 increased, 898 reduced and 357 closed positions. Its largest new stake was Kimberly-Clark: 2,442,100 shares worth $246M. The largest sale was Bank of America, an estimated $569M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Two Sigma Advisers's largest Q4 2025 buy was Kimberly-Clark: 2,442,100 shares worth $246M.
  • Two Sigma Advisers added most to ServiceNow in Q4 2025, an estimated $512M increase.
  • Two Sigma Advisers's biggest Q4 2025 reduction was Bank of America, cutting an estimated $569M.
  • Two Sigma Advisers fully exited Nebius Group in Q4 2025, selling an estimated $257M.
  • Two Sigma Advisers's ten largest holdings make up 19% of its $51.4B portfolio in Q4 2025.
  • Two Sigma Advisers opened 375 new positions and closed 357 in Q4 2025.
  • Two Sigma Advisers's portfolio value rose 2.9% quarter-over-quarter to $51.4B.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.